+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

An assessment of nursing requirements of patients with malignant neoplastic diseases

An assessment of nursing requirements of patients with malignant neoplastic diseases

Ugeskrift for Laeger 143(25): 1617-1619

Patients [80] with terminal cancer and their nursing requirements were registered prospectively during a period of 6 mo. Sixty-nine of these required nursing. When this was graduated according to a point-system, 38 patients or 47.5% required a great deal of nursing care. A total of 3/4 of the patients died during the period of investigation, 8 further patients died during the next 6 mo. A total of 95% died while hospitalized. Discharge from the hospital was only possible in 30% of the cases and this was most frequently temporary. Of 38 patients with very great nursing requirements, only 6 could be discharged. Of 31 patients with slighter nursing requirements, 13 were discharged. A total of 85% of patients suffering from intractable malignant basic disease had nursing requirements. In 47.5% the physical nursing requirements were very great; these nursing requirements were of brief duration (3/4 < 6 mo.). A total of 95% of the patients died in the hospital.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 068656936

Download citation: RISBibTeXText

PMID: 7303199

Related references

Assessment of the nursing requirements in patients with malignant disease. Ugeskrift for Laeger 143(25): 1617-1619, 1981

Incidence of coexistent essential hypertension and malignant neoplastic diseases; study based on records of 509 clinic patients with and 509 without malignant neoplasms. American Journal of the Medical Sciences 232(5): 555-559, 1956

Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases. American Journal of Medicine 54(1): 23-29, 1973

Serum cathepsin activity in patients with malignant neoplastic diseases. Medecine Interne 24(2): 121-123, 1986

Biochemical changes of the lipid in biopsied livers of patients with malignant neoplastic diseases. Tohoku Journal of Experimental Medicine 103(2): 129-139, 1971

Thromboembolic complications in patients with malignant neoplastic diseases. Autopsy material. Patologia Polska 29(1): 89-94, 1978

Bedside conference in pediatric nursing. 10. The nursing of children with respiratory diseases (No. 3), neurologic diseases (No. 2), malignant neoplasms (No. 3), hematologic diseases (No. 5) and kidney. Kango Tenbo. Japanese Journal of Nursing Science 5(10): 922-933, 1980

Nursing assessment and nursing keypoints at admission of patients with malignant lymphoma. Nursing Technique 28(9): 1153-1158, 1982

Infective endocarditis in patients treated for malignant neoplastic diseases: a postmortem study. American Journal of Clinical Pathology 60(2): 241-250, 1973

The lipid-chemical features of the biopsied human liver tissues of patients with malignant neoplastic diseases. Tohoku Journal of Experimental Medicine 118 Suppl: 149-158, 1976

On the activation of a cytostatic cyclo phosphamide anti neoplastic endoxan anti neoplastic by ionizing irradiations the possibility of the use of irradiated endoxan anti neoplastic in the therapy of neopl malignant diseases hela cell bovine serum. Sel'skokhozyaistvo za Rubezhom Rastenievodstvo 136(2): 241-249, 1968

Urinary excretion of 17-ketosteroids in patients with malignant neoplastic diseases treated with nitrogen mustards (methyl-bis chlorethylamine). Annales d'Endocrinologie 13(3): 400-406, 1952

Combined chemo therapy in patients with neopl malignant neoplasms aurantin anti neoplastic cyclo phosphane anti neoplastic thio tepa anti neoplastic. Trudy Kazakhskogo Nauchno-Issledovatel'skogo Instituta Onkologii i Radiologii (3): 276-278, 1967

Effect of oleic and linoleic acids on the monodesaturation in vitro of stearic acid by the livers of patients suffering from malignant neoplastic diseases. Tohoku Journal of Experimental Medicine 102(3): 283-288, 1970

Metabolism of neoplastic tissue. III. Diphosphopyridine nucleotide requirements for oxidations by mitochondria of neoplastic and non-neoplastic tissues. Cancer Research 13(1): 21-26, 1953